Pfizer to acquire Array BioPharma for a total enterprise value of $11.4 billion
NEW YORK: Pfizer Inc. and Array BioPharma Inc. announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array, a commercial stage biopharmaceutical company focused…